Story

The Full Story

Henkel's story over 2021–2025 is a reset. CEO Carsten Knobel, barely a year into the job, inherited a business whose consumer arm had under-earned for a decade, then used two external shocks — post-COVID input-cost inflation and the war in Ukraine — to force through the restructuring his predecessors avoided: merging Beauty Care with Laundry & Home Care, exiting Russia, and divesting ~€1B of non-strategic brands. The margin recovery that followed (adjusted EBIT margin from 10.4% in 2022 to 14.8% in 2025) is real. The growth reset is the concern: the original "Purposeful Growth" ambition of 3–4% organic sales growth has been quietly replaced by 1–3% guidance ranges, and management has stopped repeating the old target. Credibility improved on margins and portfolio execution, softened on growth.

1. The Narrative Arc

Loading...
No Results

The arc splits cleanly into two halves: 2022–2024 is a margin story (input costs → pricing → mix → portfolio cleanup), and 2025 is where that story runs out of runway and a new one has to be found. The shift from "reinvesting in brands to drive growth" (2023–2024 language) to "bolt-on M&A" + "attractive valuation" + "capital return" (2025 language) is the tell. Management is no longer promising organic re-acceleration; it is promising cash returns and deployment.

2. What Management Emphasized — and Then Stopped Emphasizing

Loading...

Three patterns matter:

  • "Purposeful Growth" has quietly faded. The 3–4% organic-sales ambition, set on January 28, 2022 alongside the merger announcement, was still the mid-term framework in 2022. By 2025 it is absent from the outlook discussion. The replacement framing is a 1–3% range presented as "clear market outperformance" rather than as hitting a pre-stated target.
  • Consumer Brands integration went from the main promise (2022–2023) to a completed project (2025). The €525M net savings target by end-2026 was pulled forward: €425M realized by end-2024, €540M by end-2025 — a year early. This is the clearest example of a specific, quantified promise delivered ahead of schedule.
  • Capital return replaced growth as the top story in 2025. The €1B buyback announced with FY2024 results, the 10% dividend hike to €2.04, then 1.5% to €2.07, plus four bolt-ons totalling €1.2B annualized sales, are the 2025 talking points. In 2022–2023 talking points were innovation spend, marketing investment, and brand-building.

3. Risk Evolution

Loading...

The risk discussion rotates in a predictable way — topics peak when the crisis is present, then fade after it is "managed." What is new in 2025 versus 2021 is not a single category but the composition: the external, inflation-era risks (raw materials, energy, pandemic) have nearly vanished, and the replacements are more structural — US tariffs, North America retailer/consumer weakness, FX translation from a weaker USD, and execution risk on the "111 approach" logistics transformation. The "111 approach" is worth flagging because it only appeared in 2024 and by 2025 was being cited as the reason for Q1 and H1 disappointment — a self-inflicted risk.

4. How They Handled Bad News

There are three legitimate "bad news" moments to examine in this window.

Episode A — FY2022 margin compression and Russia exit charges. The 2022 adjusted EBIT margin of 10.4% was roughly 300 bps below 2021 and well below the mid-term 16% ambition. The communication was honest: the chairman letter named the war directly, quantified the ~€1B Russia-related one-time charges, and presented the Consumer Brands merger as the response rather than hiding behind the externals. In contrast to peers that resisted pricing, Henkel explicitly owned pricing actions and their lag.

Episode B — Q4 2024 Adhesives slowdown and Q1 2025 soft start. Adhesive Technologies decelerated from 3.7% organic growth in Q3 2024 to ~1% in Q4, and Q1 2025 Consumer Brands was guided to -2% to -4%. The explanations given on the FY2024 call: (1) softer auto end-market, (2) "high comparables" from H1 2024 innovation launches, and (3) the "111 approach" logistics disruption. The first two are defensible. The third — disclosed only after it hit — means management rolled out a major operating-model change and let the disruption surface in the numbers before naming it externally.

Episode C — H1 2025 guidance cut. The August 2025 release lowered the FY2025 organic-growth range from 1.5–3.5% to 1.0–2.0% and the margin floor from 14.0% to 14.5%. North America weakness and "111 approach" were again cited. This is a legitimate miss relative to guidance given only five months earlier. FY2025 closed at 0.9% organic growth — below even the revised floor — though margin landed inside the revised band at 14.8%.

Across all three episodes, Henkel's disclosure style is late but specific: the company tends to reveal the negative driver only after it has materially affected results, but when it does, it names it, quantifies it, and attributes it to internal choices rather than blaming macro. That is better than most European consumer staples peers, but it does not make the miss itself go away.

5. Guidance Track Record

No Results
Loading...
Loading...

The pattern across five years:

  • Margin guidance is conservative and consistently beaten. Actual margin landed at or above the initial midpoint in 4 of 5 years, with the only miss (2022) attributable to an identified external shock. The 2024 beat was the largest — actual 14.3% vs midpoint 12.75%.
  • Sales growth guidance is more mixed. Beat materially in 2021 and 2023; missed in 2024 (slightly) and 2025 (badly — 0.9% vs midpoint 2.5%). The 2025 miss is the most damaging because it happened after three years of "under-promise, over-deliver" rhetoric.
  • EPS guidance was beaten every year, partly because management sets the range wide (-10 to +10%, then +5 to +20%, then "low to high single digits") and partly because margin mix flowed through.

Credibility score (1–10)

6.50

Credibility score: 6.5 / 10. The floor is margin and portfolio delivery: Consumer Brands integration came in a year early and €15M above target; record gross margin hit in 2024 as promised in 2022; €1B of divestitures closed as quantified. The ceiling is the top-line reset: the 3–4% organic ambition from January 2022 is de facto abandoned, the H1 2025 cut came only five months after the initial 2025 guide, and the FY2025 0.9% outcome landed below even the revised floor. Management's communication is honest and specific when it misses, which is why the score is not lower — but they have used up the "three consecutive years of promise and delivery" line.

6. What the Story Is Now

At the end of 2025 Henkel is a two-engine industrial-and-staples conglomerate with a fixed portfolio, a 14.8% adjusted EBIT margin (up ~140 bps over five years and ~300 bps off the 2022 trough), a near-zero net-debt position, an in-progress €1B buyback, and four bolt-on acquisitions from 2025 adding ~€1.2B of annualized sales. Adhesive Technologies is the quality asset: 16.7% margin, global leadership, EV/electronics tailwind — management's "best in class among our peers" description is defensible on the margin numbers. Consumer Brands is the reconstruction project: 14.5% margin (from 8.3% in 2022), top-10 brands at ~60% of sales, but 0.3% organic growth in 2025 and a logistics transformation still in flight. Post year-end, the March 2026 announcement to acquire Olaplex for $1.4B — at roughly 90% below its 2021 IPO valuation — is the loudest signal yet of the strategic pivot: buying premium hair-care brand equity rather than building it organically.

What to believe. The margin and cash story. Henkel has demonstrated it can take pricing, manage mix, cut SG&A, and finish what it starts (the merger, the savings program, the divestitures). 14.5–16% adjusted EBIT margin in 2026 guidance is plausible given the 14.8% starting point and completed integration.

What to discount. The top-line re-acceleration narrative. The 2026 1–3% range is the same shape as the 2025 range that just missed — and the "H2 stronger than H1" setup has now been the recipe for two years in a row. Assume structural ~1–2% organic growth with quality mix improvement, supplemented by M&A to hit headline growth. That is a different business than the one management described in January 2022, and the share price at roughly €68 / P/E ~13× is closer to pricing that reality than pricing the 2022 ambition.

What the reader should watch. (1) Whether the Olaplex acquisition can be integrated without another "111 approach"-type self-inflicted disruption; (2) whether Adhesive Technologies volumes can stay positive if the auto cycle weakens further; (3) whether management restates a new mid-term growth target or lets the old 3–4% ambition quietly expire without comment. The last of those will say more about management candour than any margin result.